We offer a comprehensive range of antibodies meticulously curated to meet the diverse needs of researchers and developers across various fields, including immunology, cell biology, molecular biology, and clinical diagnostics. Our collection includes monoclonal, polyclonal, and recombinant antibodies targeting a wide array of biomolecules, including proteins, peptides, carbohydrates, lipids, and nucleic acids.
These antibodies are meticulously characterized for specificity, sensitivity, and reproducibility, ensuring reliable and reproducible results in a variety of applications, including Western blotting, immunohistochemistry, flow cytometry, ELISA, and immunoprecipitation, among others.
Whether you're investigating protein expression, cellular signaling pathways, immune responses, or disease mechanisms, our antibodies provide valuable tools to support your research and development endeavors, driving innovation and advancing scientific knowledge in diverse fields.
Antibodies
Atezolizumab (anti-PD-L1), INHIBITOR of Programmed cell death 1 ligand 1 inhibitorCas#:1380723-44-3
Starting at $159.90
Avelumab (anti-PD-L1), OTHER of Programmed cell death 1 ligand 1 otherCas#:1537032-82-8
Starting at $99.90
Camrelizumab (anti-PD-1), ANTAGONIST of Programmed cell death protein 1 antagonistCas#:1798286-48-2
Starting at $39.90
- Cemiplimab (anti-PD-1), Antibody of programmed cell death 1 (CD279)
Cas#:1801342-60-8
Starting at $99.90
-
-
- Durvalumab (anti-PD-L1), INHIBITOR of Programmed cell death 1 ligand 1 inhibitor
Cas#:1428935-60-7
Starting at $39.90
-
- Ipilimumab (anti-CTLA-4), Antibody of cytotoxic T-lymphocyte-associated protein 4 (CD152)
Cas#:477202-00-9
Starting at $179.90
- Nivolumab (anti-PD-1), Antibody of programmed cell death 1 (CD279)
Cas#:946414-94-4
Starting at $159.90
- Obinutuzumab (anti-CD20), Antibody of CD20 (membrane-spanning 4-domains; subfamily A; member 1)
Cas#:949142-50-1
Starting at $99.90
- Pembrolizumab (anti-PD-1), Antibody of programmed cell death 1 (CD279)
Cas#:1374853-91-4
Starting at $39.90
- Pertuzumab (anti-HER2), Antibody of erb-b2 receptor tyrosine kinase 2
Cas#:380610-27-5
Starting at $39.90
- Ramucirumab (anti-VEGFR2), Antibody of kinase insert domain receptor
Cas#:947687-13-0
Starting at $39.90
